• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过转染丙型肝炎NS3/4A mRNA的树突状细胞进行过继转移实现的免疫与保护作用。

Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA.

作者信息

Yu Hong, Babiuk Lorne A, van Drunen Littel-van den Hurk Sylvia

机构信息

Vaccine and Infectious Disease Organization, University of Saskatchewan, 120 Veterinary Road, Saskatoon, Sask. S7N 5E3, Canada.

出版信息

Vaccine. 2007 Feb 26;25(10):1701-11. doi: 10.1016/j.vaccine.2006.11.046. Epub 2006 Dec 5.

DOI:10.1016/j.vaccine.2006.11.046
PMID:17240490
Abstract

In this study, we tested the hypothesis that adoptive transfer of dendritic cells (DCs) transfected ex vivo with mRNA encoding hepatitis C virus (HCV) NS3/4A would initiate potent HCV-specific protective immune responses in vivo. Murine DCs were transfected with NS3/4A mRNA or eGFP mRNA using either electroporation or Transmessenger Transfection Reagent and then used for adoptive transfer. Electroporation resulted in higher transfection efficiency but lower levels of eGFP and NS3/4A expression when compared to transfection with Transmessenger. The murine NS3/4A mRNA-transfected DCs were functional in T cell activation in vitro. Adoptive transfer of NS3/4A mRNA-transfected DCs resulted in migration to regional lymph nodes, strong cellular immune responses and protection from challenge with vaccinia virus expressing NS3/NS4/NS5 in mice. Furthermore, although Transmessenger mediated transfection was less efficient than electroporation in terms of number of transfected cells, the DCs transfected with NS3/4A mRNA and Transmessenger expressed higher levels of protein and induced stronger immune responses and protection than DCs transfected with NS3/4A mRNA by electroporation. Since no study has explored the in vivo efficacy of mRNA-transfected DC-mediated vaccination against viral diseases, including hepatitis C, our study provided a novel vaccination strategy against hepatitis C as well as other pathogens.

摘要

在本研究中,我们检验了以下假设:用编码丙型肝炎病毒(HCV)NS3/4A的mRNA体外转染树突状细胞(DC)后进行过继性转移,将在体内引发有效的HCV特异性保护性免疫反应。使用电穿孔或Transmessenger转染试剂将NS3/4A mRNA或eGFP mRNA转染至小鼠DC,然后用于过继性转移。与用Transmessenger转染相比,电穿孔导致更高的转染效率,但eGFP和NS3/4A表达水平较低。小鼠NS3/4A mRNA转染的DC在体外对T细胞激活具有功能性。NS3/4A mRNA转染的DC过继性转移导致其迁移至局部淋巴结,引发强烈的细胞免疫反应,并使小鼠免受表达NS3/NS4/NS5的痘苗病毒攻击。此外,尽管就转染细胞数量而言,Transmessenger介导的转染效率低于电穿孔,但用NS3/4A mRNA和Transmessenger转染的DC比用电穿孔法用NS3/4A mRNA转染的DC表达更高水平的蛋白质,并诱导更强的免疫反应和保护作用。由于尚无研究探讨mRNA转染的DC介导的疫苗接种针对包括丙型肝炎在内的病毒性疾病的体内疗效,我们的研究提供了一种针对丙型肝炎以及其他病原体的新型疫苗接种策略。

相似文献

1
Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA.通过转染丙型肝炎NS3/4A mRNA的树突状细胞进行过继转移实现的免疫与保护作用。
Vaccine. 2007 Feb 26;25(10):1701-11. doi: 10.1016/j.vaccine.2006.11.046. Epub 2006 Dec 5.
2
Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene.密码子优化和mRNA扩增可有效增强丙型肝炎病毒非结构3/4A基因的免疫原性。
Gene Ther. 2004 Mar;11(6):522-33. doi: 10.1038/sj.gt.3302184.
3
Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.一种基于腺病毒载体的丙型肝炎病毒疫苗可增强并持续诱导CD8 + T细胞应答,该疫苗编码与MHC II类伴侣蛋白恒定链相连的NS3。
J Immunol. 2011 Feb 15;186(4):2355-64. doi: 10.4049/jimmunol.1001877. Epub 2011 Jan 21.
4
Comparison of DNA- and mRNA-transfected mouse dendritic cells as potential vaccines against the human papillomavirus type 16 associated oncoprotein E7.作为针对人乳头瘤病毒16型相关癌蛋白E7的潜在疫苗的DNA转染和mRNA转染小鼠树突状细胞的比较。
Antivir Ther. 2008;13(4):495-509.
5
Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model.在一种新型小鼠攻毒模型中,用丙型肝炎病毒NS3而非核心抗原进行保护性疫苗接种。
J Gene Med. 2008 Feb;10(2):177-86. doi: 10.1002/jgm.1144.
6
Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells.通过将腺病毒颗粒靶向树突状细胞,增强针对丙型肝炎病毒的 T 细胞反应。
Hepatology. 2011 Jul;54(1):28-37. doi: 10.1002/hep.24325. Epub 2011 May 14.
7
Truncated TERT mRNA transfected dendritic cells evoke TERT specific antitumor response in vivo.截短的端粒酶逆转录酶(TERT)信使核糖核酸(mRNA)转染的树突状细胞在体内引发TERT特异性抗肿瘤反应。
Hepatogastroenterology. 2007 Apr-May;54(75):681-7.
8
In vivo clearance of hepatitis C virus nonstructural 3/4A-expressing hepatocytes by DNA vaccine-primed cytotoxic T lymphocytes.DNA疫苗引发的细胞毒性T淋巴细胞对表达丙型肝炎病毒非结构蛋白3/4A的肝细胞的体内清除作用。
J Infect Dis. 2005 Dec 15;192(12):2112-6. doi: 10.1086/498218. Epub 2005 Nov 4.
9
Heterologous T cells can help restore function in dysfunctional hepatitis C virus nonstructural 3/4A-specific T cells during therapeutic vaccination.治疗性疫苗接种中,异源 T 细胞可帮助恢复丙型肝炎病毒非结构 3/4A 特异性 T 细胞功能障碍。
J Immunol. 2011 May 1;186(9):5107-18. doi: 10.4049/jimmunol.1001790. Epub 2011 Mar 23.
10
Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3.用丙型肝炎病毒NS3蛋白脉冲处理的树突状细胞可诱导免疫反应,并对感染表达NS3的重组痘苗病毒产生保护作用。
J Gen Virol. 2006 Jan;87(Pt 1):1-10. doi: 10.1099/vir.0.81423-0.

引用本文的文献

1
Advances in nanoparticle-based mRNA delivery for liver cancer and liver-associated infectious diseases.基于纳米颗粒的 mRNA 递送至肝癌和肝相关传染病的研究进展。
Nanoscale Horiz. 2022 Dec 20;8(1):10-28. doi: 10.1039/d2nh00289b.
2
Ribonucleic Acid Engineering of Dendritic Cells for Therapeutic Vaccination: Ready 'N Able to Improve Clinical Outcome?用于治疗性疫苗接种的树突状细胞的核糖核酸工程:是否已准备好并能够改善临床结果?
Cancers (Basel). 2020 Jan 27;12(2):299. doi: 10.3390/cancers12020299.
3
RNA-based drugs and vaccines.基于RNA的药物和疫苗。
Expert Rev Vaccines. 2015 Feb;14(2):253-63. doi: 10.1586/14760584.2015.959932. Epub 2014 Sep 14.
4
Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles.核酸疫苗的研制:脂质纳米粒中自我扩增 RNA 的应用。
Int J Nanomedicine. 2014 Apr 10;9:1833-43. doi: 10.2147/IJN.S39810. eCollection 2014.
5
CD8(+) T-cell priming and boosting: more antigen-presenting DC, or more antigen per DC?CD8(+) T 细胞的初始激活和增强:更多的抗原呈递树突状细胞,还是每个树突状细胞上更多的抗原?
Cancer Immunol Immunother. 2013 Dec;62(12):1769-80. doi: 10.1007/s00262-013-1481-z. Epub 2013 Oct 10.
6
Evaluation of the immunogenicity of liposome encapsulated HVR1 and NS3 regions of genotype 3 HCV, either singly or in combination.评估单独或联合使用脂质体包封的 HCV 基因型 3 的 HVR1 和 NS3 区的免疫原性。
Virol J. 2012 Mar 27;9:74. doi: 10.1186/1743-422X-9-74.
7
Dendritic cells in hepatitis C infection: can they (help) win the battle?丙型肝炎感染中的树突状细胞:它们能(帮忙)赢得这场战斗吗?
J Gastroenterol. 2011 Apr;46(4):432-47. doi: 10.1007/s00535-011-0377-y. Epub 2011 Feb 17.
8
Electroporation advances in large animals.电穿孔技术在大动物中的进展。
Curr Gene Ther. 2009 Aug;9(4):316-26. doi: 10.2174/156652309788921062.